Prognostic value of residual cancer burden after neoadjuvant taxane-anthracycline chemotherapy in phenotypic subsets of breast cancer

被引：0
|
作者：
Hubbard, R.
Peintinger, F.
Liedtke, C.
Hatzis, C.
Kuerer, H. M.
Valero, V.
Buzdar, A. U.
Hortobagyi, G. N.
Pusztai, L.
Symmans, W. F.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Gen Hosp Loeben, Leoben, Austria
[3] Nuvera Biosci Inc, Woburn, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.544
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
544
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A Genomic Predictor of Survival Following Taxane-Anthracycline Chemotherapy for Breast Cancer
    Symmans, W. F.
    Hatzis, C.
    Valero, V.
    Booser, D. J.
    Esserman, L.
    Martin, M.
    Vidaurre, T.
    Holmes, F.
    Souchon, E. A.
    Lluch, A.
    Cotrina, J.
    Gomez, H.
    Hubbard, R.
    -Lozano, J. Ferrer
    Dyer, R.
    Buxton, M.
    Gong, Y.
    Wu, Y.
    Ibrahim, N.
    Andreopoulou, E.
    Ueno, N. T.
    Hunt, K.
    Yang, W.
    Nazario, A.
    DeMichele, A.
    O'Shaughnessy, J.
    Hortobagyi, G. N.
    Pusztai, M. D. L.
    CANCER RESEARCH, 2010, 70
  • [2] Reproducibility of residual cancer burden for prognostic assessment of breast cancer after neoadjuvant chemotherapy
    Peintinger, Florentia
    Sinn, Bruno
    Hatzis, Christos
    Albarracin, Constance
    Downs-Kelly, Erinn
    Morkowski, Jerzy
    Gould, Rebekah
    Symmans, W. Fraser
    MODERN PATHOLOGY, 2015, 28 (07) : 913 - 920
  • [3] Prognostic value of residual cancer burden and Miller-Payne system after neoadjuvant chemotherapy for breast cancer
    Wang, Wei
    Liu, Yinhua
    Zhang, Hong
    Zhang, Shuang
    Duan, Xuening
    Ye, Jingming
    Xu, Ling
    Zhao, Jianxin
    Cheng, Yuanjia
    Liu, Qian
    GLAND SURGERY, 2021, 10 (12) : 3211 - +
  • [4] Prognostic value of residual cancer burden after neoadjuvant chemotherapy in breast cancer: a comprehensive subtype-specific analysis
    Soo-Young Lee
    Tae-Kyung Yoo
    Sae Byul Lee
    Jisun Kim
    Il Yong Chung
    Beom Seok Ko
    Hee Jeong Kim
    Jong Won Lee
    Byung Ho Son
    Scientific Reports, 15 (1)
  • [5] The residual cancer burden index as a valid prognostic indicator in breast cancer after neoadjuvant chemotherapy
    Xu, Xin
    Zhao, Wei
    Liu, Cuicui
    Gao, Yongsheng
    Chen, Dawei
    Wu, Meng
    Li, Chao
    Wang, Xinzhao
    Song, Xiang
    Yu, Jinming
    Liu, Zhaoyun
    Yu, Zhiyong
    BMC CANCER, 2024, 24 (01)
  • [6] The residual cancer burden index as a valid prognostic indicator in breast cancer after neoadjuvant chemotherapy
    Xin Xu
    Wei Zhao
    Cuicui Liu
    Yongsheng Gao
    Dawei Chen
    Meng Wu
    Chao Li
    Xinzhao Wang
    Xiang Song
    Jinming Yu
    Zhaoyun Liu
    Zhiyong Yu
    BMC Cancer, 24
  • [7] Residual Cancer Burden After Neoadjuvant Chemotherapy in Breast Cancer Patients
    Elder, E. A.
    Livasy, C.
    Donahue, E.
    Neelands, B. J.
    Patrick, A.
    Needham, M.
    Sarantou, T.
    Hadzikadic-Gusic, L.
    White, R.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 1) : S53 - S53
  • [8] A Genomic Predictor of Response and Survival Following Taxane-Anthracycline Chemotherapy for Invasive Breast Cancer
    Hatzis, Christos
    Pusztai, Lajos
    Valero, Vicente
    Booser, Daniel J.
    Esserman, Laura
    Lluch, Ana
    Vidaurre, Tatiana
    Holmes, Frankie
    Souchon, Eduardo
    Wang, Hongkun
    Martin, Miguel
    Cotrina, Jose
    Gomez, Henry
    Hubbard, Rebekah
    Ignacio Chacon, J.
    Ferrer-Lozano, Jaime
    Dyer, Richard
    Buxton, Meredith
    Gong, Yun
    Wu, Yun
    Ibrahim, Nuhad
    Andreopoulou, Eleni
    Ueno, Naoto T.
    Hunt, Kelly
    Yang, Wei
    Nazario, Arlene
    DeMichele, Angela
    O'Shaughnessy, Joyce
    Hortobagyi, Gabriel N.
    Symmans, W. Fraser
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (18): : 1873 - 1881
  • [9] Genes involved in TLR4 signal transduction as prognostic factors for survival following Taxane-Anthracycline neoadjuvant chemotherapy for invasive breast cancer
    Pinto, J.
    Valdiviezo, P.
    Aguilar, A.
    Flores, C.
    Velazco, R.
    Suazo, J.
    Vallejos, C.
    Gomez, H.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S35 - S36
  • [10] Prognostic value of the residual cancer burden after neoadjuvant chemotherapy for invasive lobular breast cancer: An international pooled cohort study
    Gottipati, S.
    Earl, H. M.
    Yau, C.
    Cameron, D. A.
    Abraham, J.
    Hayward, L.
    Reyal, F.
    Osdoit, M.
    Sonke, G. S.
    Wesseling, J.
    Boughey, J.
    Goetz, M. P.
    DeMichele, A.
    Pusztai, L.
    Sharma, P.
    Martin Jimenez, M.
    Lopez-Tarruella Cobo, S.
    Del Monte-Millan, M.
    Symmans, F.
    Mukhtar, R.
    ANNALS OF ONCOLOGY, 2023, 34 : S325 - S326
12345